Inhalation

INH1021

Issue link: https://www.e-digitaleditions.com/i/1417310

Contents of this Issue

Navigation

Page 30 of 37

Inhalation OctOber 2021 29 DPI development and manufacturing services Experic's experienced team provides customized and scalable filling, packaging and logistics solu- tions at clinical and commercial scale for reservoir and single-dose dry powder inhalation devices. From early development and manufacturing for any single-dose unit, to clinical trial supplies and logistics, Experic offers services that can solve dry powder inhaler (DPI) manufacturing challenges, accelerate time to market, and mitigate risk for products with a range of properties, particle sizes, doses and throughput requirements. Experic LLC US: +1 888 397-9733 https://expericservices.com Supporting in vitro bioequivalence e expansion at Intertek's Centre of Excellence for Inhaled and Nasal Drug Development in Melbourn, UK has focused on powerful in vitro analytical strat- egies such as realistic flow profiles, lung dissolution and Morphologically Directed Raman Spectros- copy (MDRS) to help clients overcome challenges of clinical bioequivalence studies. Our 30 years of experience in supporting our clients' development from concept through to marketing approval is built on our strengths in method development/validation, testing, stability, product characterization, device screening, CMC studies, formulation development and clinical manufacturing support. Intertek UK: +44 1763 261648 www.intertek.com

Articles in this issue

Links on this page

view archives of Inhalation - INH1021